Skip to main content
Other
Response to the FDA Draft Guidance for Industry document: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims (Docket 2006D-0044)
Quantitative Health Sciences Publications and Presentations
  • Jakob B. Bjorner, QualityMetric Inc.
  • Barbara Gandek, QualityMetric Inc.
  • Jason Cole, QualityMetric Inc.
  • Mark Kosinski, QualityMetric Inc.
  • Gene Wallenstein, QualityMetric Inc.
  • Milena Anatchkova, QualityMetric Inc.
  • John E. Ware, Jr., University of Massachusetts Medical School
UMMS Affiliation
Department of Quantitative Health Sciences
Publication Date
12-1-2006
Document Type
Response or Comment
Subjects
Outcome Assessment (Health Care); Product Labeling; Research; Health Care Sector
Rights and Permissions
Citation: Bjorner, J. B., Gandek B., Cole, J. C., Kosinski, M., Wallenstein, G. V., Anatchkova, M., and Ware J.E., Jr. Response to the FDA Draft Guidance for Industry document: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims (Docket 2006D-0044). 2006.
Citation Information
Jakob B. Bjorner, Barbara Gandek, Jason Cole, Mark Kosinski, et al.. "Response to the FDA Draft Guidance for Industry document: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims (Docket 2006D-0044)" (2006)
Available at: http://works.bepress.com/john_ware/8/